Triptodur (triptorelin) is a prescription drug that’s used to treat central precocious puberty. Triptodur can cause side effects that range from mild to serious. Examples include infection and ...

This marks the first gonadotropin-releasing hormone (GnRH) agonist approved for dosing once every 6 months for CPP. Arbor announced that the Food and Drug Administration (FDA) has approved Triptodur ...

Triptodur, a gonadotropin-releasing hormone (GnRH) agonist, is given as an intramuscular (IM) injection every 6 months. Arbor and Debiopharm announced the launch of Triptodur (triptorelin ...

CPP is a condition involving the premature onset of puberty in girls younger than 8 years old and boys younger than 9 years old. Triptodur is a hormone agonist designed to regulate hormone levels and ...

Triptodur ', (triptorelin) for extended release injectable suspension, has been shown to arrest or reverse the clinical signs of puberty with onceevery six-monthintramuscular injection (IM) dosing for ...

ATLANTA y LAUSANA, Suiza, 4 de octubre de 2017 /PRNewswire/ -- Triptodur™, (triptorelina) suspensión inyectable de liberación lenta, ha demostrado detener o anular los signos clínicos de la pubertad ...

Triptodur(TM), (triptorelin) extended release injectable suspension, has been shown to arrest or reverse the clinical signs of puberty associated with CPP via a once every six-month intramuscular (IM) ...

Triptodur can cause certain side effects, some of which are more common than others. These side effects may be temporary, lasting a few days to weeks. However, if the side effects last longer than ...

Arbor Pharmaceuticals, LLC, a U.S. based specialty pharmaceutical company, and Debiopharm International SA, part of Debiopharm Group', a Swiss-based global biopharmaceutical company, announced today ...

Triptodur™, (triptorelin) for extended release injectable suspension, has been shown to arrest or reverse the clinical signs of puberty with once every six-month intramuscular injection (IM) dosing ...

Triptodur(TM), (triptorelin) for extended release injectable suspension, has been shown to arrest or reverse the clinical signs of puberty with once every six-month intramuscular injection (IM) dosing ...

"We are pleased to be providing this important new treatment option for children diagnosed with CPP," said Ed Schutter, President and CEO of Arbor. "We believe that many providers, patients and ...